From Nov. 2 to 3, the 2018 Submit Forum on Immunology and Clinical Application (SFICA) was held successfully in Nanjing, China. Prof. Bin Zhang, from Northwestern University, as the special guest, had an excellent speech on “Targeting CD73 to improve cancer immunotherapy”. We were honored to have an interview with Prof. Zhang.
